Regeneus secures ethics approval to collect stem cells for off-the-shelf … – Proactive Investors Australia
Proactive Investors AustraliaRegenerative medicine company Regeneus (ASX: RGS) has received the key ethics approval to collect stem cells from human donors for the production of its new allogeneic off-the-shelf stem cell product for osteoarthritis. It can now begin manufacturing …Regeneus scores stem cells ethics approvalFinance News Network all 2 news articles …read more &nbs… Continue reading
